PBS updates

Kimmtrak (tebentafusp)

tebentafusp 100 microgram/0.5 mL injection, 0.5 mL vial · INJECTION · PBS code 13832B

AUTHORITY_REQUIRED

What it costs

AU$17583.56 PBS-determined price per pack

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2024-02-01.
  • • Repeats: 0.
  • • PBS program: IP.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Advanced (unresectable or metastatic) uveal melanoma


Initial treatment - day 1


Patient must have HLA-A*02:01-positive disease; AND

Patient must have uveal melanoma that has been confirmed either (i) histologically, (ii) cytologically; AND

The treatment must be the sole PBS-subsidised therapy for this condition; AND

Patient must not have received prior systemic therapy for metastatic disease; AND

Patient must be at least 18 years of age.

According to the TGA-approved Product Information, hospitalisation is recommended at minimum for the first 3 doses (on Days 1, 8 and 15) and for at least 16 hours after each infusion is completed. If the patient does not experience hypotension that is Grade 2 or worse (requiring medical intervention) with the third dose, subsequent doses can be administered in an appropriate outpatient/ambulatory care setting. Supervision by a health care professional is recommended for a minimum of 30 minutes following each infusion.

This drug is not PBS-subsidised if it is administered to an in-patient in a public hospital setting.

Positive HLA-A*02:01 assessment must be documented in the patient's medical records.

Sponsor: MEDISON PHARMA AUSTRALIA PTY LIMITED ABN 19 659 723 403

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.